spacer
home > pmps > winter 2019 > embracing spray drying strategies
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Embracing Spray Drying Strategies

Orally inhaled drug products have several therapeutic advantages over other dosage forms − most notably, a more direct delivery to the central nervous system. By their very nature, they avoid the first pass effect through the liver, for both regional as well as systemic delivery. This allows drug developers to formulate delivery strategies that reduce the dosage strength and limit the risk of adverse side effects. While pharmaceutical companies have long recognised the potential of inhalation products, many are starting to explore development techniques such as spray drying in more depth.

This article will outline the benefits of using respirable-engineered dry powder for inhalation products, as well as discussing how the new 505 (b) (2) application route for faster approval of new formulations that use existing APIs is a suitable pathway to getting these products to market quickly and efficiently.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
Aditya R Das PhD, MBA is Director of Business Development at Recipharm and is focussed on inhalation drug product development and commercialisation for global clients. He is responsible for coordinating the interface between client needs and external services and capabilities to facilitate optimal product development and global registration. Aditya has over 25 years’ experience working in combination biopharmaceutical product development, including pulmonary, transdermal, intravenous, implanted, and oral drug delivery therapeutic strategies and is an inventor on eight issued patents. He has a PhD in chemical engineering, an MBA from the University of California, US, an MS degree in chemical engineering from Carnegie Mellon University, US, and a BS degree in chemical engineering from the University of New Hampshire, US.
spacer
Aditya R Das PhD, MBA
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm accelerates strategy to broaden service offering into commercial manufacturing

MedPharm Ltd, a leading contract provider of topical and transdermal product design and development services, has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
More info >>

White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement